BCYC - Company ID 0001761612
The table below shows BICYCLE THERAPEUTICS plc's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $72.59M | $35.27M | $26.98M | $14.46M | $11.70M | $10.39M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $240.28M | $172.97M | $156.50M | $81.61M | $44.88M | $33.15M |
| SG&A |
BICYCLE THERAPEUTICS plc reported annual revenue of $72.59M for fiscal year 2025. That is up 105.8% from $35.27M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $2.06M (FY 2017) to $72.59M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $79.37M |
| $72.18M |
| $60.43M |
| $49.51M |
| $32.44M |
| $29.20M |
| Operating income | -$247.06M | -$209.87M | -$189.95M | -$116.65M | -$65.62M | -$51.96M |
| Income tax | $152.00K | -$4.76M | $1.46M | -$1.52M | -$1.66M | -$724.00K |
| Net income | -$218.96M | -$169.03M | -$180.66M | -$112.72M | -$66.82M | -$51.01M |
| EPS (diluted) | -$3.16 | -$2.90 | -$5.08 | -$3.80 | -$2.67 | -$2.66 |